Page 497 - IJB-9-6
P. 497

International Journal of Bioprinting                              Bioprinting cell-laden protein-based hydrogel




            the regulations on tissue and organ donation specific to   is another problem impairing their capability to form
            each of the countries. All in all, a shift toward allogeneic   stable constructs; this matter can be solved by blending
            sourcing necessitates collaboration among research   them with other biopolymers. Besides, the fundamental
            groups, companies, and regulatory bodies in defining   challenges in bioprinting of keratin, elastin, and resilin
            more standardized regulations on tissue and organ   are poor extensibility, possibility of contaminations after
            donation.  Besides,  biological,  physical,  and  biochemical   the purification process, and difficulty in determining the
            requirements of cartilage and bone tissues in designing   molecular sequence and primary sequence of resilin owing
            PBHs are sometimes overlooked, representing an issue   to the diminished stability during the purification.
            that should be addressed in order to obtain accurate   Despite the rapid advances of bioprinting approaches
            experimental results in this field.                in recent years, the above-mentioned obstacles should be
               Natural proteins, including collagen, gelatin, silk   surmounted to move this field forward. Regarding the
            fibroin, fibrin, keratin, elastin, and resilin, are in the   PBHs, successful examples on the development of cartilage-
            spotlight of  investigations  on  PBHs. However, each   and bone-engineered constructs employing bioprinting
            displays several drawbacks that should be overcome to   strategies have been described. As stated, several factors,
            achieve favorable outcomes. In the case of collagen-based   including biophysical and biochemical parameters, and
            bioinks, bioprinting of pure collagen is rather complex   PBHs’ process considerations must be taken into account,
            because of its low viscosity; a suggested solution in this   and multiple challenges with respect to these subjects
            regard is combining it with viscous polymers. Additionally,   are required to be overcome to ultimately translate these
            to enhance its shape fidelity, physical crosslinking and   concepts into clinics in the foreseeable future.
            blending with other polymers can be employed. Other
            hindrances in the bioprinting of collagen that need to   6. Conclusion
            be addressed are poor mechanical strength and rapid   In bioprinting, there is a paramount need to address
            hydrolysis. A common problem of pure gelatin bioinks   the cell damage caused by shear stress and to develop
            at physiological temperature is their low viscosity, which   bioinks with ideal cell protection. Researchers have been
            can be also improved when blending them with viscous   employing experimental investigations and probabilistic
            polymers. Another obstacle, again solvable via combining   models to understand cell encapsulation in droplets
            with other polymers, is associated with the low bioprinting   and to design bioinks with suitable characteristics.
            resolution of these bioinks. Notably, to augment their poor   Notably, current single-cell bioprinting techniques have
            shape  fidelity,  post-printing  crosslinking  and  utilizing   limitations in terms of throughput and deviation in the
            external support for the bioinks have been demonstrated   printing process. In addition, reproducing complex cell–
            as effective methods. Unfortunately, the stress shielding   matrix and cell–cell interactions is a significant challenge
            features of gelatin bioinks are low; a complication that   for other bioprinting methods. Future directions include
            can be tackled by nozzle temperature optimization during   developing tissue repair printers, equipping bioprinters
            bioprinting to increase cellular survival. Pure silk bioinks   with microfluidic heads, and designing gradient scaffolds.
            have the disadvantage of high viscosity, resulting in   Of note, combining different bioprinting approaches,
            nozzle clogging at the time of bioprinting; one efficacious   evaluating cellular functions, and optimizing factors like
            strategy involves using recombinant silk that possesses   imaging and bioink formulations are ongoing trends to
            lower viscosity compared to that of the native silk.   advance the bioprinting field. Protein-based materials
            Furthermore, lacking cell binding domains which can   display promise for bioinks but may have batch-to-batch
            limit cellular attachment, low cellular growth and function   variations. It is important to mention that establishing
            support, and the absence of an established protocol for the   strict protocols for protein concentration, purification, and
            optimization of silk-based bioinks are other obstacles that   extraction is crucial to ensure reliable and reproducible
            need to be taken into account. Particularly, scholars should   outcomes  in  bioprinting.  Selecting  the  best  method  of
            address the high rate of enzymatic degradation and poor   sterilization is also critical for the safety and properties
            mechanical parameters related to the silk fibroin bioinks   of the final bioink. In addition, ethical concerns and
            as well as the weak structural integrity associated with   pathogen transmission risks arise when using proteins
            the silk sericin bioinks. The chief challenge of employing   from xenogeneic sources, while allogeneic sources are
            fibrin as a bioink is its irreversible and rapid gelation at   limited  in  availability due  to  regulations  on tissue  and
            the body temperature, making its bioprinting intricate.   organ donation. In this regard, a collaboration between
            As an alternative, fibrinogen and thrombin blends can be   research groups, companies, and regulatory bodies is
            printed together at low temperatures in order to inhibit   required to standardize regulations on tissue and organ
            early crosslinking. The fast degradation of fibrin bioinks   donation for allogeneic sourcing. Natural proteins such

            Volume 9 Issue 6 (2023)                        489                          https://doi.org/10.36922/ijb.1089
   492   493   494   495   496   497   498   499   500   501   502